XML 39 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Avinza Co-Promotion (Tables)
 12 Months Ended
Dec. 31, 2013
Co Promotion [Abstract]  
Summary of co-promote termination liability
A summary of the co-promote termination liability as of December 31, 2013 and 2012 is as follows (in thousands):
 
Net present value of payments based on estimated future net Avinza product sales as of December 31, 2011
$
21,452

Assumed payments made by Pfizer or assignee
(3,479
)
Fair value adjustments due to passage of time
(5,439
)
Net present value of payments based on estimated future net Avinza product sales as of December 31, 2012
12,534

Assumed payments made by Pfizer or assignee
(3,310
)
Fair value adjustments due to passage of time
2,522

Total co-promote termination liability as of December 31, 2013
11,746

Less: current portion of co-promote termination liability as of December 31, 2013
4,329

Long-term portion of co-promote termination liability as of December 31, 2013
$
7,417